{"id":"https://openalex.org/W4396804283","doi":"https://doi.org/10.1186/s12943-024-02012-z","title":"DLL3-guided therapies in small-cell lung cancer: from antibody-drug conjugate to precision immunotherapy and radioimmunotherapy","display_name":"DLL3-guided therapies in small-cell lung cancer: from antibody-drug conjugate to precision immunotherapy and radioimmunotherapy","publication_year":2024,"publication_date":"2024-05-10","ids":{"openalex":"https://openalex.org/W4396804283","doi":"https://doi.org/10.1186/s12943-024-02012-z","pmid":"https://pubmed.ncbi.nlm.nih.gov/38730427","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11084107"},"language":"en","primary_location":{"id":"doi:10.1186/s12943-024-02012-z","doi":"https://doi.org/10.1186/s12943-024-02012-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12943-024-02012-z","pdf_url":null,"source":{"id":"https://openalex.org/S132829192","display_name":"Molecular Cancer","issn_l":"1476-4598","issn":["1476-4598"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1186/s12943-024-02012-z","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046508238","display_name":"Po\u2010Lan Su","orcid":"https://orcid.org/0000-0002-8470-6590","observed_orcids":["https://orcid.org/0000-0002-8470-6590"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]},{"id":"https://openalex.org/I91807558","display_name":"National Cheng Kung University","ror":"https://ror.org/01b8kcc49","country_code":"TW","type":"education","lineage":["https://openalex.org/I91807558"]}],"countries":["TW","US"],"is_corresponding":false,"raw_author_name":"Po-Lan Su","raw_affiliation_strings":["Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng-Li Rd., North District, Tainan, 704, Taiwan","Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 494 Biomedical Research Tower, 460 W 10th Ave., Columbus, OH, 43210, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng-Li Rd., North District, Tainan, 704, Taiwan","institution_ids":["https://openalex.org/I4210158999","https://openalex.org/I91807558"]},{"raw_affiliation_string":"Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 494 Biomedical Research Tower, 460 W 10th Ave., Columbus, OH, 43210, USA","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111216557","display_name":"Karthik Chakravarthy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I4405282248","display_name":"Pelotonia","ror":"https://ror.org/05jcvqz82","country_code":"US","type":"funder","lineage":["https://openalex.org/I4405282248"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karthik Chakravarthy","raw_affiliation_strings":["Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 494 Biomedical Research Tower, 460 W 10th Ave., Columbus, OH, 43210, USA","The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH, 43210, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 494 Biomedical Research Tower, 460 W 10th Ave., Columbus, OH, 43210, USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH, 43210, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I4405282248"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078647935","display_name":"Naoki Furuya","orcid":"https://orcid.org/0000-0001-7162-5946","observed_orcids":["https://orcid.org/0000-0001-7162-5946"]},"institutions":[{"id":"https://openalex.org/I163917720","display_name":"St. Marianna University School of Medicine","ror":"https://ror.org/043axf581","country_code":"JP","type":"education","lineage":["https://openalex.org/I163917720"]},{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Naoki Furuya","raw_affiliation_strings":["Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 494 Biomedical Research Tower, 460 W 10th Ave., Columbus, OH, 43210, USA","Division of Respiratory Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 494 Biomedical Research Tower, 460 W 10th Ave., Columbus, OH, 43210, USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"Division of Respiratory Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan","institution_ids":["https://openalex.org/I163917720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060861700","display_name":"Jeremy M. Brownstein","orcid":"https://orcid.org/0000-0002-2820-4895","observed_orcids":["https://orcid.org/0000-0002-2820-4895"]},"institutions":[{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy Brownstein","raw_affiliation_strings":["Department of Radiation Oncology, The Ohio State University Wexner Medical Center, 460 W 10th Ave., Columbus, OH, 43210, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, The Ohio State University Wexner Medical Center, 460 W 10th Ave., Columbus, OH, 43210, USA","institution_ids":["https://openalex.org/I2802841970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109627190","display_name":"Jianhua Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jianhua Yu","raw_affiliation_strings":["Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Rd., Duarte, Los Angeles, CA, 91010, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Rd., Duarte, Los Angeles, CA, 91010, USA","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082915839","display_name":"Meixiao Long","orcid":"https://orcid.org/0000-0002-0820-5612","observed_orcids":["https://orcid.org/0000-0002-0820-5612"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I4405282248","display_name":"Pelotonia","ror":"https://ror.org/05jcvqz82","country_code":"US","type":"funder","lineage":["https://openalex.org/I4405282248"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meixiao Long","raw_affiliation_strings":["Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH, 43210, USA","The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH, 43210, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH, 43210, USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH, 43210, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I4405282248"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059652753","display_name":"David Paul Carbone","orcid":"https://orcid.org/0000-0003-3002-1921","observed_orcids":["https://orcid.org/0000-0003-3002-1921"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I4405282248","display_name":"Pelotonia","ror":"https://ror.org/05jcvqz82","country_code":"US","type":"funder","lineage":["https://openalex.org/I4405282248"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Carbone","raw_affiliation_strings":["Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 494 Biomedical Research Tower, 460 W 10th Ave., Columbus, OH, 43210, USA","The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH, 43210, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 494 Biomedical Research Tower, 460 W 10th Ave., Columbus, OH, 43210, USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH, 43210, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I4405282248"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002360335","display_name":"Zihai Li","orcid":"https://orcid.org/0000-0003-4603-927X","observed_orcids":["https://orcid.org/0000-0003-4603-927X"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I4405282248","display_name":"Pelotonia","ror":"https://ror.org/05jcvqz82","country_code":"US","type":"funder","lineage":["https://openalex.org/I4405282248"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zihai Li","raw_affiliation_strings":["Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 494 Biomedical Research Tower, 460 W 10th Ave., Columbus, OH, 43210, USA","The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH, 43210, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 494 Biomedical Research Tower, 460 W 10th Ave., Columbus, OH, 43210, USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH, 43210, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I4405282248"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075792907","display_name":"Kai He","orcid":"https://orcid.org/0000-0002-4378-9297","observed_orcids":["https://orcid.org/0000-0002-4378-9297"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I4405282248","display_name":"Pelotonia","ror":"https://ror.org/05jcvqz82","country_code":"US","type":"funder","lineage":["https://openalex.org/I4405282248"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kai He","raw_affiliation_strings":["Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 494 Biomedical Research Tower, 460 W 10th Ave., Columbus, OH, 43210, USA. kai.he@osumc.edu","The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH, 43210, USA. kai.he@osumc.edu","The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH, 43210, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 494 Biomedical Research Tower, 460 W 10th Ave., Columbus, OH, 43210, USA. kai.he@osumc.edu","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH, 43210, USA. kai.he@osumc.edu","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I4405282248"]},{"raw_affiliation_string":"The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH, 43210, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I4405282248"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5075792907"],"corresponding_institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I4405282248"],"apc_list":{"value":4890,"currency":"USD","value_usd":4890},"apc_paid":{"value":4890,"currency":"USD","value_usd":4890},"fwci":11.1014,"has_fulltext":true,"cited_by_count":69,"citation_normalized_percentile":{"value":0.99174595,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"23","issue":"1","first_page":"97","last_page":"97"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dll3","display_name":"DLL3","score":0.9980000257492065},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8299999833106995},{"id":"https://openalex.org/keywords/tarlatamab","display_name":"tarlatamab","score":0.878000020980835},{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.9800000190734863},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8009999990463257},{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.949999988079071},{"id":"https://openalex.org/keywords/ascl1","display_name":"ASCL1","score":0.8889999985694885},{"id":"https://openalex.org/keywords/notch-signaling","display_name":"Notch signaling","score":0.9259999990463257},{"id":"https://openalex.org/keywords/rovalpituzumab-tesirine","display_name":"rovalpituzumab tesirine","score":0.9089999794960022},{"id":"https://openalex.org/keywords/trispecific-t-cell-engager","display_name":"trispecific T cell engager","score":0.828000009059906},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7788103818893433},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.6877133846282959},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5973358750343323},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5191758871078491},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.5083412528038025},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42245739698410034},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42146414518356323},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.4139578342437744},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4125576615333557},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.4117574989795685},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3643907308578491},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35615620017051697},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2981977164745331},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2948988676071167},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.20652437210083008}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D047908","descriptor_name":"Intracellular Signaling Peptides and Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D055752","descriptor_name":"Small Cell Lung Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055752","descriptor_name":"Small Cell Lung Carcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D055752","descriptor_name":"Small Cell Lung Carcinoma","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D055752","descriptor_name":"Small Cell Lung Carcinoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/s12943-024-02012-z","doi":"https://doi.org/10.1186/s12943-024-02012-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12943-024-02012-z","pdf_url":null,"source":{"id":"https://openalex.org/S132829192","display_name":"Molecular Cancer","issn_l":"1476-4598","issn":["1476-4598"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11084107","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11084107","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11084107/pdf/12943_2024_Article_2012.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Cancer","raw_type":"Text"},{"id":"pmid:38730427","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38730427","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer","raw_type":"Review"},{"id":"pmh:oai:doaj.org/article:d10fc426c38f4600bcf76fa725a89e1b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d10fc426c38f4600bcf76fa725a89e1b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Cancer, Vol 23, Iss 1, Pp 1-5 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12943-024-02012-z","doi":"https://doi.org/10.1186/s12943-024-02012-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12943-024-02012-z","pdf_url":null,"source":{"id":"https://openalex.org/S132829192","display_name":"Molecular Cancer","issn_l":"1476-4598","issn":["1476-4598"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1738736228","display_name":"Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin","funder_award_id":"R01NS106170","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G8990492194","display_name":"Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells","funder_award_id":"R01CA247550","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000903559","display_name":"Phase 1 Evaluation of Enhanced Natural Killer Cells as a Treatment Strategy in Non-Small cell Lung Cancer Patients Refractory to PD-1/PD-L1 Immune Checkpoint Inhibitors","funder_award_id":"R01CA266457","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4396804283.pdf","grobid_xml":"https://content.openalex.org/works/W4396804283.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W2560431464","https://openalex.org/W2949179770","https://openalex.org/W2973098277","https://openalex.org/W3124749091","https://openalex.org/W3132559292","https://openalex.org/W3151827122","https://openalex.org/W4205702495","https://openalex.org/W4210450943","https://openalex.org/W4286298695","https://openalex.org/W4308383141","https://openalex.org/W4311587798","https://openalex.org/W4317776094","https://openalex.org/W4379345564","https://openalex.org/W4381943608","https://openalex.org/W4387799038","https://openalex.org/W4393166252"],"related_works":["https://openalex.org/W4405087727","https://openalex.org/W4381943608","https://openalex.org/W2949179770","https://openalex.org/W4410849502","https://openalex.org/W7117765420","https://openalex.org/W4386782720","https://openalex.org/W4410792171","https://openalex.org/W7162667113","https://openalex.org/W4409511574","https://openalex.org/W3036045424"],"abstract_inverted_index":{"DLL3":[0,32,151],"acts":[1],"as":[2],"an":[3],"inhibitory":[4],"ligand":[5],"that":[6],"downregulates":[7],"Notch":[8],"signaling":[9],"and":[10,43,94,118,145,155,160,204],"is":[11,113],"upregulated":[12],"by":[13],"ASCL1,":[14],"a":[15,57,104],"transcription":[16],"factor":[17],"prevalent":[18],"in":[19,56,67,103],"the":[20,28,74,99,136],"small-cell":[21],"lung":[22],"cancer":[23],"(SCLC)":[24],"subtype":[25],"SCLC-A.":[26],"Currently,":[27],"therapeutic":[29,177],"strategies":[30],"targeting":[31,150],"are":[33,156],"varied,":[34],"including":[35],"antibody-drug":[36],"conjugates":[37],"(ADCs),":[38],"bispecific":[39,144],"T-cell":[40,48,141],"engagers":[41],"(BiTEs),":[42],"chimeric":[44],"antigen":[45],"receptor":[46],"(CAR)":[47],"therapies.":[49],"Although":[50],"rovalpituzumab":[51],"tesirine":[52],"(Rova-T)":[53],"showed":[54],"promise":[55],"phase":[58,69,105,125],"II":[59,106],"study,":[60],"it":[61],"failed":[62],"to":[63,73,98,129,180,208],"produce":[64],"favorable":[65],"results":[66],"subsequent":[68],"III":[70,126],"trials,":[71],"leading":[72],"cessation":[75],"of":[76,101,138],"its":[77,108],"development.":[78],"Conversely,":[79],"DLL3-targeted":[80,140,172,183],"BiTEs":[81],"have":[82,152,167],"garnered":[83],"significant":[84],"clinical":[85,133,162,192],"interest.":[86],"Tarlatamab,":[87],"for":[88,171,188,197],"instance,":[89],"demonstrated":[90],"enhanced":[91],"response":[92],"rates":[93],"progression-free":[95],"survival":[96,211],"compared":[97],"standard":[100],"care":[102],"trial;":[107],"biologics":[109],"license":[110],"application":[111],"(BLA)":[112],"currently":[114],"under":[115],"US":[116],"Food":[117],"Drug":[119],"Administration":[120],"(FDA)":[121],"review.":[122],"Numerous":[123],"ongoing":[124],"studies":[127,166],"aim":[128],"further":[130],"evaluate":[131],"tarlatamab's":[132],"efficacy,":[134],"alongside":[135],"development":[137],"novel":[139],"engagers,":[142],"both":[143],"trispecific.":[146],"CAR-T":[147],"cell":[148],"therapies":[149,184,207],"recently":[153],"emerged":[154],"undergoing":[157],"various":[158,202],"preclinical":[159,165],"early-phase":[161],"studies.":[163],"Additionally,":[164],"shown":[168],"promising":[169],"efficacy":[170],"radiotherapy,":[173],"which":[174],"employs":[175],"\u03b2-particle-emitting":[176],"radioisotopes":[178],"conjugated":[179],"DLL3-targeting":[181],"antibodies.":[182],"hold":[185],"substantial":[186],"potential":[187],"SCLC":[189],"management.":[190],"Future":[191],"trials":[193],"will":[194],"be":[195],"crucial":[196],"comparing":[198],"treatment":[199],"outcomes":[200],"among":[201],"approaches":[203],"exploring":[205],"combination":[206],"improve":[209],"patient":[210],"outcomes.":[212]},"counts_by_year":[{"year":2026,"cited_by_count":35},{"year":2025,"cited_by_count":27},{"year":2024,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-05-11T00:00:00"}